Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?

References

• Armon C. Sports and trauma in ALS revisited. J Neurol Sci. 2007;262:45–53.
   PubMed Web of Science ®Google Scholar
• Wallin MT, Kurtzke JF. Neuroepidemiology. Chap. 39 in Bradley's Neurology in Clinical Practice. 6th edn. Philadelphia: Elsevier Saunders; 2012. pp 687–703.
   Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial ALS: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011; 82:623–7.
   PubMed Web of Science ®Google Scholar
• Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, et al. The C9orf72 expansion mutation is a common cause of ALS +/− FTD in Europe and has a single founder. Eur J Hum Genet 2012 June 13. (Epub ahead of print).
   Web of Science ®Google Scholar
• Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, Marangi G, et al. Contribution of major ALS genes to the etiology of sporadic disease. Neurology. 2012;79:66–72.
   PubMed Web of Science ®Google Scholar
• Blauw HM, Barnes CP, van Vught PW, van Rheenen W, Verheul M, Cuppen E, et al. SMN1 gene duplications are associated with sporadic ALS. Neurology. 2012;78: 776–80.
   PubMed Web of Science ®Google Scholar
• van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, et al. Angiogenin variants in Parkinson's disease and amyotrophic lateral sclerosis. Ann Neurol. 2011;70:964–73.
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.
   PubMed Web of Science ®Google Scholar
• Qureshi IA, Mehler MF. Advances in epigenetics and epigenomics for neurodegenerative diseases. Curr Neurol Neurosci Rep. 2011;11:464–73.
   PubMed Web of Science ®Google Scholar
• Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323–30.
   PubMed Web of Science ®Google Scholar
• Johnson FO, Atchison WD. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology. 2009;30: 761–5.
   PubMed Web of Science ®Google Scholar
• Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, et al. Association between blood lead and risk of ALS. Am J Epidemiol. 2010;171:1126–33.
   PubMed Web of Science ®Google Scholar
• Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MH, et al. Exposure to chemicals and metals and risk of ALS: a systematic review. Amyotroph Lateral Scler. 2009;10:302–9.
   PubMed Web of Science ®Google Scholar
• Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151:156–63.
   PubMed Web of Science ®Google Scholar
• Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009;73:1693–8.
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205–9.
   PubMed Web of Science ®Google Scholar
• Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970–4.
   PubMed Web of Science ®Google Scholar
• McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol. 2010;69:918–29.
   PubMed Web of Science ®Google Scholar
• Savica R, Parisi JE, Wold LE, Josephs KA, Ahlskog JE. High school football and risk of neurodegeneration: a community based study. Mayo Clinic Proc. 2012;87:335–40.
   PubMed Web of Science ®Google Scholar
• Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, Allen KD, et al. Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology. 2008;31:28–32.
   PubMed Web of Science ®Google Scholar
• Miranda ML, Galeano MAO, Tassone E, Allen KD, Horner RD. Spatial analysis of the etiology of ALS among 1991 Gulf War veterans. Neurotoxicology. 2008; 29:96–970.
   Web of Science ®Google Scholar
• Johnson RT, Bradley WG, Ritz BR, Rocca WA, Shefner JM, Wolfson C. Committee on the Review of the Scientific Literature on Amyotrophic Lateral Sclerosis in Veterans. Institute of Medicine. Washington, DC.: National Academies of Science Press, 2006.
   Google Scholar
• Cox PA, Richer R, Metcalf JS, Banack SA, Codd GA, Bradley WG. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph Lateral Scler. 2009;10 (Suppl 2): 109–17.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, McCullough ML, Morozova N, Calle EE, Thun MJ. Prospective study of occupation and amyotrophic lateral sclerosis mortality. Am J Epidemiol. 2005;162:1146–52.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, Morozova N, O’Reilly EJ, McCullough ML, Calle EE, Thun MJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:558–61.
   PubMed Web of Science ®Google Scholar
• Govoni V, Granieri E, Fallica E, Casetta I. Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964–1998. J Neurol. 2005;252:1322–7.
   PubMed Web of Science ®Google Scholar
• Furby A, Beauvais K, Kolev I, Rivain JG, Senille V. Rural environment and risk factors of ALS: a case-control study. J Neurol. 2010;257:792–8.
   PubMed Web of Science ®Google Scholar
• Kamel F, Umbach DM, Lehman TA, Park LP, Munsat TL, Shefner JM, et al. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ Health Perspect. 2003;111:1335–9.
   PubMed Web of Science ®Google Scholar
• van Blitterswijk M, Blokhuis A, van Es MA, van Vught PW, Rowicka PA, Schelhaas HJ, et al. Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients. Neurobiol Aging. 2012 Feb 11. (Epub ahead of print)
   Google Scholar
• Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW. Occurrence of beta-methylamino-L-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand. 2004;110:267–9.
   PubMed Web of Science ®Google Scholar
• Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci. 2004;101:12228–31.
   PubMed Web of Science ®Google Scholar
• Ince PG, Codd GA. Return of the cycad hypothesis – does the amyotrophic lateral sclerosis/POarkinsonism dementia complex (ALS/PDC) of Guam have implications for global health?Neuropathol Appl Neurobiol. 2005;31:345–53.
   PubMed Web of Science ®Google Scholar
• Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A, et al. Cycad exposure and risk of dementia, MCI and PDC in the Chamorro population of Guam. Neurology. 2007;68:1764–71.
   PubMed Web of Science ®Google Scholar
• Bradley WG, Cox PA. Beyond Guam: BMAA and sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;(Suppl 2):1–126.
   PubMed Web of Science ®Google Scholar
• Cox PA, Banack SA, Murch SJ, Rasmussen U, Tien G, Bidigare RR, et al. Diverse taxa of cyanobacteria produce β-N-methylamino-L-alanine, a neurotoxic amino acid. Proc Natl Acad Sci. 2005;102:5074–8.
   PubMed Web of Science ®Google Scholar
• Banack SA, Johnson HE, Cheng R, Cox PA. Production of the neurotoxin BMAA by a marine cyanobacterium. Marine Drugs. 2007;5:180–96.
   PubMed Web of Science ®Google Scholar
• Downing S, Banack SA, Metcalf JS, Cox PA, Downing TG. Nitrogen starvation of cyanobacteria results in the production of β-N-methylamino-L-alanine. Toxicon. 2011; 58:187–94.
   PubMed Web of Science ®Google Scholar
• Downing S, van de Venter M, Downing TG. The effect of exogenous β-N-methyalmino-L-alanine on the growth of Synechocystis PCC6803.Microb Ecol. 2012;63: 149–56.
   PubMed Web of Science ®Google Scholar
• Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with particular reference to the Mariana Islands, including clinical and pathologic observations. Neurology. 1954;4:338–48, 355–78.
   Google Scholar
• Plato CC, Reed DM, Elizan TS, Kurland LT. Amyotrophic lateral sclerosis/Parkinsonism-dementia complex of Guam. IV. Familial and genetic investigations.Am J Hum Genet. 1967;19:617–32.
   PubMed Web of Science ®Google Scholar
• Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, et al. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003;157:149–57.
   PubMed Web of Science ®Google Scholar
• Reed D, Plato C, Elizan T, Kurland LT. The amyotrophic lateral sclerosis/Parkinsonism-dementia complex: a 10-year follow-up on Guam. I. Epidemiologic studies. Am J Epidemiol. 1966;83:54–73.
   PubMed Web of Science ®Google Scholar
• Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, et al. Incidence of amyotrophic lateral sclerosis and of the Parkinsonism-dementia complex of Guam, 1950–1989. Neuroepidemiology. 2004;23:192–200.
   PubMed Web of Science ®Google Scholar
• Kuzuhara S. ALS/Parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease). Historical review, epidemiology and concept. Rinsho Shinkeigaku. 2007;47:962–5.
   PubMedGoogle Scholar
• Bradley WG, Mash DC. Beyond Guam: the cyanobacteria BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler. 2009;10 (Suppl 2):7–20.
   PubMedGoogle Scholar
• Lee S. Guam dementia syndrome revisited in 2011. Curr Opin Neurol. 2011;24:517–24.
   PubMed Web of Science ®Google Scholar
• Bell EA. The discovery of BMAA, and examples of biomagnification and protein incorporation involving other non-protein amino acids. Amyotroph Lateral Scler. 2009;10(Suppl 2):21–5.
   PubMedGoogle Scholar
• Spencer PS, Nunn PB, Hougon J, Ludolph AC, Roy DN, Ross SM, et al. Guam amyotrophic lateral sclerosis/ Parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987;31:517–22.
   Google Scholar
• Dastur DK. Cycad toxicity in monkeys: clinical, pathological and biochemical aspects. Fed Proc. 1964;23: 1368–9.
   PubMedGoogle Scholar
• Dastur DK, Palekar RS, Manghani DK. Toxicity of various forms of Cycas circinalis in rhesus monkeys: pathology of brain, spinal cord and liver. In: Rose FC, Norris FH, editors. Amyotrophic lateral sclerosis, Chapter 18. New advances in toxicology and epidemiology. London: Smith-Gordon; 1990. pp 129–41.
   Google Scholar
• Duncan MW, Koplin IJ, Garruto RM, Lavine L, Markey SP. 2-Amino-3(methylamino)-propionic acid in cycad-derived foods is an unlikely cause of ALS/Parkinsonism. Lancet. 1988;2:631–2.
   PubMed Web of Science ®Google Scholar
• Cox PA, Sacks OW. Cycad neurotoxin, consumption of fruit bats, and ALS/PDC disease in Guam. Neurology. 2002;59:1664–5.
   PubMed Web of Science ®Google Scholar
• Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology. 2002;61:387–9.
   Web of Science ®Google Scholar
• Banack SA, Murch SJ, Cox PA. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 2006;106:97–104.
   PubMed Web of Science ®Google Scholar
• Banack SA, Cox PA, Murch SJ. 2010. Flying Fox Consumption and Human Neurodegenerative Disease in Guam. In: Fleming TH, Racey PA, editors. Island Bats: Evolution, Ecology, and Conservation. Chicago: University of Chicago Press; 2010. pp 341–66.
   Google Scholar
• Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Nat Acad Sci. 2003;100:13380–3.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Li K, Perl DP, Galasko D. Lack of beta- methylaminol-alanine in brain from controls, AD, or Chamorros with PDC. Neurology. 2005;65:768– 9.
   PubMed Web of Science ®Google Scholar
• Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. Lack of cerebral BMAA in human cerebral cortex. Neurology. 2009;72:1360– 1.
   PubMed Web of Science ®Google Scholar
• Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2008;70:1984– 90.
   PubMed Web of Science ®Google Scholar
• Cox PA, Banack SA. A Non-protein Amino Acid and Neurodegeneration. Science. 2006;314:1242.
   PubMed Web of Science ®Google Scholar
• Cox PA, Banack SA, Murch SJ. Cyanobacteria, Cycads, and Neurodegenerative Disease among the Chamorro People of Guam. In: Vovides AP, Stevenson DW, Osborne R, editors. Proceedings of Cycad 2005: The 7th International Conference on Cycad Biology. New York: New York Botanical Garden Press; 2007. pp 253–85.
   Google Scholar
• Lee M, McGeer PL. Weak BMAA toxicity compares with that of the dietary supplement beta-alanine. Neurobiol Aging. 2012;33:1440–7.
   PubMed Web of Science ®Google Scholar
• Allende CC, Allende JE. Purification and substrate specificity of arginyl-ribonucleic acid synthetase from rat liver. J Biol Chem. 1964;239:1102–6.
   PubMed Web of Science ®Google Scholar
• Xie X, Mondo K, Basile MJ, Bradley WG, Mash DC. Tracking brain uptake and protein incorporation of cyanobacterial toxin BMAA. Amyotroph Lateral Scler. 2011;12 (Suppl 1):22.
   Google Scholar
• Rodgers K, Dunlop R. The cyanobacteria-derived BMAA can be incorporated into cell proteins and could thus be an environmental trigger for ALS and other neurological diseases associated with protein misfolding. Amyotroph Lateral Scler. 2011;12(Suppl 1):22.
   Google Scholar
• Dunlop R, Rodgers K. Proteins containing BMAA form autofluorescent aggregates and induce cell death. Amyotroph Lateral Scler. 2011;12(Suppl 1):156.
   Google Scholar
• Fogg GE, Stewart WDP, Fay P, Walsby AE. The Blue-Green Algae. London and NewYork: Academic Press; 1973.
   Google Scholar
• Codd GA. Cyanobacterial toxins, the perception of water quality and the prioritization of eutrophication control. Ecological Engineering. 2000;16:51–60.
   Web of Science ®Google Scholar
• Codd GA, Lindsay J, Young FM, Morrison LF, Metcalf J. Harmful cyanobacteria: from mass mortalities to management measures. In: Huisman J, Matthijs HCP, Visser PM, editors. Harmful Cyanobacteria. Dordrecht: Springer; 2005. pp 1–23.
   Google Scholar
• Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae. 2010;9:620–35.
   PubMed Web of Science ®Google Scholar
• Paul VJ. Global warming and cyanobacterial harmful algal blooms. Adv Exp Med Biol. 2008;619:239–57.
   PubMed Web of Science ®Google Scholar
• Paerl HW, Huisman J. Blooms like it hot. Science. 2008;320: 57–8.
   PubMed Web of Science ®Google Scholar
• Boyer GL, Watzin MC, Shambaugh AD, Satchwell MF, Rosen BH, Mihuc T. The Occurrence of Cyanobacteria Toxins in Lake Champlain. In: Manley TO, Manley PL, Mihuc TB, editors. Lake Champlain: Partnerships and Research in the new Millennium. New York: Kluwer Academic/Plenum Press; 2004. pp 241–58.
   Google Scholar
• Codd GA, Morrison LF, Metcalf JS. Cyanobacterial toxins: risk management for health protection. Toxicol Appl Pharmacol. 2005;203:264–72.
   PubMed Web of Science ®Google Scholar
• Codd GA, Azevedo SMFO, Bagchi SN, Burch MD, Carmichael WW, Harding WR, et al. CYANONET: a global network for cyanobacterial bloom and toxin risk management. 2005. http://www.unesco.org
   Google Scholar
• Yu S-Z. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol. 1995;10:674–82.
   PubMed Web of Science ®Google Scholar
• Svircev Z, Krstic S, Miladinov-Mikov M, Baltic V, Vidovic M. Freshwater cyanobacterial blooms and primary liver cancer epidemiological studies in Serbia. J Environ Sci Health C, Environ Carcinog Ecotoxicol Rev. 2009; 27:36–55.
   PubMed Web of Science ®Google Scholar
• Fleming L, Rivero C, Burns J, Williams C, Bean J, Shea K, et al. Blue-green algal (cyanobacterial) toxins, surface drinking water, and liver cancer in Florida. Harmful Algae. 2002;1:157–68.
   Google Scholar
• Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, et al. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease. Acta Neurol Scand. 2009;120:216–25.
   PubMed Web of Science ®Google Scholar
• Brand LE, Pablo J, Compton A, Hammerschlag N, Mash DC. Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae. 2010 1;9:620–35.
   Google Scholar
• Mondo K, Hammerschlag N, Basile M, Pablo J, Banack SA, Mash DC. Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Marine Drugs. 2012;10:509–20.
   PubMed Web of Science ®Google Scholar
• Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol. 1990;47:38–41.
   Google Scholar
• Sabel CE, Boyle PJ, Löytönen M, Gatrell AC, Jokelainen M, Flowerdew R, Maasilta P. Spatial clustering of ALS in Finland at place of birth and place of death. Am J Epidemiol. 2003;157:898–905.
   PubMed Web of Science ®Google Scholar
• Sabel CE, Boyle P, Raab G, Loytonen M, Maasilta P. Modelling individual space-time exposure opportunities: a novel approach to unraveling the genetic or environmental disease causation debate. Spat Spatiotemporal Epidemiol. 2009;1:85–94.
   PubMedGoogle Scholar
• Sabel CE, Gatrell AC, Löytönen M, Maasilta P, Jokelainen M. Modeling exposure opportunities: estimating relative risk for motor neuron disease in Finland. Soc Sci Med. 2000;50:1121–37.
   PubMed Web of Science ®Google Scholar
• Jonasson S, Eriksson J, Berntzon L, Spácil Z, Ilag LL, Ronnevi LO, et al. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc Nat Acad Sci. 2010;18: 9252–7.
   Google Scholar
• Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler. 2009;10(Suppl 2): 101–8.
   PubMed Web of Science ®Google Scholar
• Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler. 2012;13:25–32.
   PubMed Web of Science ®Google Scholar
• Corcia P, Jafari-Schluep HF, Lardillier D, Mazyad H, Giraud P, Clavelou P, et al. A clustering of conjugal ALS in south-east France. Arch Neurol. 2003;60:553–7.
   PubMedGoogle Scholar
• Masseret E, Banack S, Boumediene F, Abadie E, Brient L, Vaquer A, et al. Detection of BMAA in the marine environment of a sporadic ALS cluster in southern France. Amyotroph Lateral Scler. 2011;12(Suppl 1):21.
   Google Scholar
• Codd GA, Bell SG, Kaya K, Ward CJ, Beattie KA, Metcalf JS. Cyanobacterial toxins, exposure routes and human health. Eur J Phycol. 1999;34:405–15.
   Web of Science ®Google Scholar
• Pierce RH, Henry MS, Blum PC, Lyons J, Cheng YS, Yazzie D, et al. Brevetoxin concentrations in marine aerosol: human exposure levels during a Karenia brevis harmful algal bloom. Bull Environ Contam Toxicol. 2003;70:161–5.
   PubMed Web of Science ®Google Scholar
• Backer LB, McNeel SV, Barber T, Kirkpatrick B, Williams C, Irvin M, et al. Recreational Exposure to Microcystins During Algal Blooms in Two California Lakes. Toxicon. 2010;55:909–21.
   PubMed Web of Science ®Google Scholar
• Esterhuizen M, Pflugmacher S, Downing TG.β-N-methylamino-L-alanine (BMAA) uptake by the aquatic macrophyte Ceratophyllum demersum. Ecotoxicol Environ Saf. 2011;74:74–7.
   Google Scholar
• Dietrich DR, Fischer A, Michel C, Hoeger SJ. Toxin mixture in cyanobacterial blooms: a critical comparison of reality with current procedures employed in human health risk assessment. Adv Exp Med Biol. 2008;619:885–912.
   PubMed Web of Science ®Google Scholar
• Metcalf JS, Richer R, Cox PA, Codd GA. Cyanotoxins in desert environments may present a risk to human health. Sci Total Environ. 2012;421–422:118–23.
   PubMed Web of Science ®Google Scholar
• Garruto RM, Gajdusek C, Chen KM. Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann Neurol. 1980;8:612–9.
   PubMed Web of Science ®Google Scholar
• Garruto RM, Gajdusek DC, Chen KM. Amyotrophic lateral sclerosis and Parkinsonism-dementia among Filipino migrants to Guam. Ann Neurol. 1981;10:341–50.
   PubMed Web of Science ®Google Scholar
• Ajdacic-Gross V, Wang J, Gutzwiller F. Season of birth in ALS. Eur J Epidemiol. 1998;14:359–61.
   PubMed Web of Science ®Google Scholar
• Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California. Am J Epidemiol. 2009;169: 919–26.
   PubMed Web of Science ®Google Scholar
• Florida Fish and Wildlife Conservation Commission. Resource Guide for Public Health Response to Harmful Algal Blooms in Florida. FWRI Technical Report TR-14, 2009. http://www.myfloridaeh.com/medicine/aquatic/resourceguidepublichealth.pdf
   Google Scholar
• Brakhage P. The Nebraska Experience. Lakeline, vol. 29, no. 2, summer 2009. http://www.deq.state.ne.us/Publica.nsf/a9f87abbcc29fa1f8625687700625436/dc50a548157633e786257590005cec58/$FILE/LakeLine-Cyanobacteria.pdf
   Google Scholar
• Roney HC, Booth GM, Cox PA. Competitive exclusion of cyanobacterial species in the Great Salt Lake. Extremophiles. 2009;13:355–61.
   PubMed Web of Science ®Google Scholar
• Bigham DL, Hoyer MV, Canfield DE. Survey of toxic algal (microcystin) distribution in Florida lakes. Lake and Reservoir Management. 2009;25:264–75.
   Web of Science ®Google Scholar
• Zaias J, Backer LC, Fleming LE. Harmful Algal Blooms. In: Rabinowitz PM, Conti LA, editors. Human Animal Medicine: Clinical Approaches to Zoonoses, Toxicants, and Other Shared Health Risks. Maryland Heights, Missouri: Sanders; 2010. pp 91–104.
   Google Scholar
• Nyakairu GWA, Nasgawa CB, Mbabazi J. Assessment of cyanobacteria toxins in freshwater fish: a case study of Murchison Bay (Lake Victoria) and Lake Mburo, Uganda. Toxicon. 2010;55:939–46.
   PubMed Web of Science ®Google Scholar
• Florida LAKEWATCH 2011. http://lakewatch.ifas.ufl.edu.
   Google Scholar
• Institute for Water Resources. 2011 M&I Water Supply Database. http://www.iwr.usace.army.mil/docs/iwrreports/2012-R-02.pdf
   Google Scholar
• United States Environmental Protection Agency 2012. Drinking Water Data and Databases. http://water.epa.gov/scitech/datait/databases/drink/
   Google Scholar
• United States Geological Survey 2012. Water Data for the Nation. http://waterdata.usgs.gov/nwis
   Google Scholar
• ALS Consortium of Epidemiologic Studies (ACES). http://aces.stanford.edu/ForRes.html
   Google Scholar
• Meriluoto J, Codd GA. TOXIC: Cyanobacterial monitoring and cyanotoxin analysis. Abo Akademi, Finland: Abo Akademi University Press; 2005.
   Google Scholar
• Whitmore T, Riedinger M. Sedimented algal pigment profiles in Florida lakes. Florida Department of Environmental Protection. Tallahassee, 2002. http://www.dep.state.fl.us/water/wqssp/nutrients/docs/meetings/Algal_Pigments_Final.pdf.
   Google Scholar
• van Metre PC, Wilson JT, Fuller CC, Callender E, Mahler BJ. Collection, analysis, and age dating of sediment cores from 56 U.S. lakes and reservoirs sampled by the U.S. Geological Survey, 1992–2001: U.S. Geological Survey Scientific Investigations Report 2004–5184, 180 pp.
   Google Scholar
• Ritchie JC, McHenry JR. Determination of fallout 137Cs and naturally occurring gamma-ray emitters in sediments. Int J Appl Radiat Isot. 1973;24:575–8.
   PubMedGoogle Scholar
• Ritchie JC, McHenry JR, Gill AC. Dating recent reservoir sediments. Limnol Oceanog. 1973;18:254–63.
   Web of Science ®Google Scholar
• Bellucci LG, Frignani M, Cochran JK, Albertazzo S, Zaggia L, Cecconi G, et al. 210Pb and 137Cs as chronometers for salt marsh accretion in the Venice lagoon. J Environ Radioactiv. 2007;97:85–102.
   PubMed Web of Science ®Google Scholar
• Metcalf JS, Banack SA, Lindsay J, Morrison LF, Cox PA, Codd GA. Co-occurrence of β-N-methylamino-L-alanine, a neurotoxic amino acid, with other cyanobacterial toxins in British water bodies, 1990–2004. Environ Microbiol. 2008;10:702–8.
   PubMed Web of Science ®Google Scholar
• Metcalf JS, Beattie KA, Purdie EL, Bryant JA, Irvine LM, Codd GA. Analysis of microcystins and microcystin genes in 60- to 170-year-old dried herbarium specimens of cyanobacteria. Harmful Algae. 2012:15:47–52.
   Web of Science ®Google Scholar
• Tyler AN, Hunter PD, Carvalho L, Codd GA, Elliott JA, Ferguson CA, et al. Strategies for monitoring and managing mass populations of toxic cyanobacteria in recreational waters: a multi-interdisciplinary approach. Environ Health. 2009;8(Suppl 1):S11.
   PubMedGoogle Scholar
• Hunter PD, Tyler AN, Carvalho L, Codd GA, Maberley S. Hyperspectral remote sensing of cyanobacterial pigments as indicators for cell populations and toxins in eutrophic lakes. Remote Sensing of Environment. 2010;114:2705–18.
   Web of Science ®Google Scholar
• Wynne TT, Stumpf RP, Tomlinson MC, Schwab DJ, Watabayashi GY, Christensen JD. Estimating cyanobacterial bloom transport by coupling remotely sensed imagery and a hydrodynamic model. Ecol Appl. 2011;21:2709–21.
   PubMed Web of Science ®Google Scholar
• Agha R, Cirés S, Wörmer L, Domínguez JA, Quesada A. Multi-scale strategies for the monitoring of freshwater cyanobacteria: reducing the sources of uncertainty. Water Res. 2012 Mar 16. (Epub ahead of print)
   PubMed Web of Science ®Google Scholar
• Ramos AG, Martel A, Codd GA, Soler E, Cioca J, Redondo A, et al. Bloom of the marine diazotrophic cyanobacteium Trichodesmium erythraeum in the north-west African Upwelling. Marine Ecology Progress Series. 2005; 301:303–5.
   Web of Science ®Google Scholar
• Grany JR, Dvonch JT, Keeler GJ. Use of multi- element tracers to source apportion mercury in south Florida aerosols. Atmospheric Environment. 2004;38: 1715–26.
   Web of Science ®Google Scholar
• Rush T, Liu XQ, Lobner D. Synergistic toxicity of the environmental neurotoxins methylmercury and β-N- methylamino-L-alanine. Neuroreport. 2012;23:216–9.
   PubMed Web of Science ®Google Scholar
• Smith QR, Nagura H, Takada Y, Duncan MW. Facilitated transport of the neurotoxin, β-N-methylamino-L-alanine, across the blood-brain barrier. J Neurochem. 1992;58: 1330–7.
   PubMed Web of Science ®Google Scholar
• Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature. 2006;443:50–5.
   PubMed Web of Science ®Google Scholar
• Latour P, Thauvin-Robinet C, Baudelet-Méry C, Soichot P, Cusin V, Faivre L, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet. 2010; 86:77–82.
   PubMed Web of Science ®Google Scholar
• Stum M, McLaughlin HM, Kleinbrink EL, Miers KE, Ackerman SL, Seburn KL, et al. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci. 2011;46:432–43.
   PubMed Web of Science ®Google Scholar
• Sieh W, Choi Y, Chapman NH, Craig UK, Steinbart EJ, Rothstein JH, et al. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet. 2009; 18:3725–38.
   PubMed Web of Science ®Google Scholar
• Kühne A, Kaiser R, Schirmer M, Heider U, Muhlke S, Niere W, et al. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side-effects of melphalan. Pharmacogenetics Genomics. 2007;17:505–17.
   PubMed Web of Science ®Google Scholar